Brought to you by 
Pulse Biosciences nets $18.4mm through initial public offering
Jun 2016
Executive Summary
Pulse Biosciences Inc. (pulsed electric field technology to treat cancer and skin conditions) netted $18.4mm through its initial public offering of 5mm common shares at $4.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com